Pasar al contenido principal

REACTIVACION OPTOGENETICA Y NEUROPROTECCION COMO TERAPIA DE ENFERMEDADES NEURODEGENERATIVAS DE LA RETINA.

BFU2015-67139-R

•
Nombre agencia financiadora Ministerio de Economía y Competitividad
Acrónimo agencia financiadora MINECO
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2015
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Unidad de gestión Dirección General de Investigación Científica y Técnica
Centro beneficiario UNIVERSIDAD DE ALICANTE
Identificador persistente http://dx.doi.org/10.13039/501100003329

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

RUA. Repositorio Institucional de la Universidad de Alicante
Publicación Otros (Other)

Loss of Melanopsin-Expressing Ganglion Cell Subtypes and Dendritic Degeneration in the Aging Human Retina

  • Esquiva, Gema
  • Lax, Pedro
  • Pérez-Santonja, Juan J.
  • García-Fernández, José M.
  • Cuenca, Nicolás
  • Cuenca, Nicolás|||/items/9aff7e32-82c7-4c3b-9e61-c644ea7f9ec8
  • Esquiva, Gema|||/items/c732fed4-c592-4084-9dc2-20bebb68f96c
  • Lax, Pedro|||/items/4cc55375-3e6f-40f5-b3dc-8b55eb7dd8a7
In mammals, melanopsin-expressing retinal ganglion cells (mRGCs) are, among other things, involved in several non-image-forming visual functions, including light entrainment of circadian rhythms. Considering the profound impact of aging on visual function and ophthalmic diseases, here we evaluate changes in mRGCs throughout the life span in humans. In 24 post-mortem retinas from anonymous human donors aged 10–81 years, we assessed the distribution, number and morphology of mRGCs by immunostaining vertical retinal sections and whole-mount retinas with antibodies against melanopsin. Human retinas showed melanopsin immunoreactivity in the cell body, axon and dendrites of a subset of ganglion cells at all ages tested. Nearly half of the mRGCs (51%) were located within the ganglion cell layer (GCL), and stratified in the outer (M1, 12%) or inner (M2, 16%) margin of the inner plexiform layer (IPL) or in both plexuses (M3, 23%). M1 and M2 cells conformed fairly irregular mosaics, while M3 cell distribution was slightly more regular. The rest of the mRGCs were more regularly arranged in the inner nuclear layer (INL) and stratified in the outer margin of the IPL (M1d, 49%). The quantity of each cell type decrease after age 70, when the total number of mRGCs was 31% lower than in donors aged 30–50 years. Moreover, in retinas with an age greater than 50 years, mRGCs evidenced a decrease in the dendritic area that was both progressive and age-dependent, as well as fewer branch points and terminal neurite tips per cell and a smaller Sholl area. After 70 years of age, the distribution profile of the mRGCs was closer to a random pattern than was observed in younger retinas. We conclude that advanced age is associated with a loss in density and dendritic arborization of the mRGCs in human retinas, possibly accounting for the more frequent occurrence of circadian rhythm disorders in elderly persons.
RUA. Repositorio Institucional de la Universidad de Alicante
Publicación Otros (Other)

Norgestrel, a Progesterone Analogue, Promotes Significant Long-Term Neuroprotection of Cone Photoreceptors in a Mouse Model of Retinal Disease

  • Roche, Sarah L.
  • Kutsyr, Oksana
  • Cuenca, Nicolás
  • Cotter, Thomas G.
  • Cuenca, Nicolás|||/items/9aff7e32-82c7-4c3b-9e61-c644ea7f9ec8
Purpose: Retinitis pigmentosa (RP) refers to a group of inherited blinding retinal diseases, whereby the death of mutated rod photoreceptors is followed closely by the death of cone photoreceptors. Cone cell death can be hugely debilitating as color/daytime vision becomes impaired. Thus, treatments that are effective against cone cell death are urgently needed. Our research has been working toward development of a neuroprotective treatment for RP. We have previously demonstrated significant neuroprotective properties of norgestrel, a progesterone analogue, in the mouse retina. The current study further investigates the potential of norgestrel as a treatment for RP, with a focus on long-term preservation of cone photoreceptors. Methods: Using the well-established rd10 mouse model of RP, we administered a norgestrel-supplemented diet at postnatal day (P)30, following widespread loss of rod photoreceptors and at the outset of cone degeneration. We subsequently assessed cone cell morphology and retinal function at P50, P60, and P80, using immunohistochemistry, electroretinograph recordings, and optomotor testing. Results: While cone cell degeneration was widespread in the untreated rd10 retina, we observed profound preservation of cone photoreceptor morphology in the norgestrel-treated mice for at least 50 days, out to P80. This was demonstrated by up to 28-fold more cone arrestin-positive photoreceptors. This protection transpired to functional preservation at all ages. Conclusions: This work presents norgestrel as an incredibly promising long-term neuroprotective compound for the treatment of RP. Crucially, norgestrel could be used in the mid-late stages of the disease to protect remaining cone cells and help preserve color/daytime vision.
RUA. Repositorio Institucional de la Universidad de Alicante
Publicación Otros (Other)

Effects of environmental factors and neuroprotective compounds on oxidative stress and inflammation in retinal neurodegenerative diseases

  • Kutsyr, Oksana
La retina es un tejido fotosensible que se localiza tapizando la pared posterior del globo ocular. Está formada por múltiples capas de células bien organizadas y cuya correcta sincronización permite el correcto procesamiento de la información visual. Cuando alguno de los componentes de este complejo sistema falla, se desencadena un proceso degenerativo en la retina. La pérdida de visión es uno de los problemas de salud dominantes en la población, ya que los pacientes pierden notablemente calidad de vida. Así, una de las principales causas de pérdida de visión es la degeneración de los fotorreceptores (principales células fotosensibles de la retina) asociada a enfermedades neurodegenerativas hereditarias. La retinosis pigmentaria (RP) se considera una de las enfermedades hereditarias de la retina más comunes, y que conduce finalmente a la ceguera. Actualmente, las enfermedades neurodegenerativas de la retina se consideran incurables y su proceso degenerativo, una vez iniciado, es difícil de frenar. De esta manera, las estrategias terapéuticas actuales se centran en el descubrimiento y desarrollo de nuevos compuestos neuroprotectores. Por otro lado, también es de gran importancia conocer cuáles son los posibles factores externos que pueden influir en el progreso de la enfermedad. El primer objetivo de esta tesis doctoral fue estudiar el efecto de la deleción del receptor tipo Toll 4 (TLR4) en la estructura y función de la retina de ratón. TLR4 juega un papel importante en la embriogénesis, la diferenciación celular, el desarrollo de las neuronas y su conectividad. De esta manera, en la retina de ratón adulto se observó que la deleción genética de este receptor altera ligeramente la función de la retina e induce una disminución de la mensidad de la microglía. Así, el TLR4 podría estar involucrado en el establecimiento de la correcta estructura retiniana y su regulación podría modular el proceso degenerativo de enfermedades neurodegenerativas de la retina. Otros dos objetivos de esta tesis doctoral fueron evaluar el efecto neuroprotector de dos compuestos (el compuesto ITH12674 y el fármaco sitagliptina) en el proceso degenerativo de la retina del ratón rd10, modelo de RP. Por un lado, el compuesto ITH12674 tiene propiedades antinflamatorias y antioxidantes. Este compuesto fue capaz de mejorar la respuesta funcional y la morfología de las células de la retina en comparación con los ratones control. El tratamiento con ITH12674 en ratones rd10 redujo el estado inflamatorio de la retina y aumentó la liberación de moléculas involucradas en la autofagia. Este estudio proporciona una prueba de concepto útil para seguir desarrollando y optimizando derivados de este compuesto con el fin de aplicarlo en un futuro en el tratamiento de la RP. Por otro lado, el fármaco sitagliptina es un inhibidor de la dipeptidil peptidasa IV y tiene propiedades hipoglucemiantes y antinflamatorias. Este fármaco mostró una capacidad para preservar la función, así como, la morfología y conectividad de las células de la retina y disminuyó el estado inflamatorio de la retina. Además, este fármaco no actúa únicamente a través de mecanismos sistémicos, sino que también tiene efectos locales en el tejido. Por tanto, el uso de sitagliptina podría ser útil en el tratamiento de la RP. Por último, otros dos objetivos de esta tesis doctoral fueron analizar los efectos de dos factores ambientales, como son la iluminación ambiental y la ingesta de una dieta rica en grasa, sobre la degeneración de la retina en ratones rd10. Por un lado, se eligieron tres intensidades de iluminación correspondientes a los tres tipos de visión (escotópica, mesópica y fotópica). Los resultados de este estudio mostraron que la intensidad de iluminación ambiental es un factor importante capaz de exacerbar la degeneración retiniana induciendo una pérdida de función en la retina, así como una remodelación de las distintas capas de la retina. Este estudio pone de manifiesto que la protección de la retina contra el daño inducido por luz podría ser una buena estrategia para ralentizar la progresión de la enfermedad. Por otro lado, el consumo de dietas ricas en grasa induce neuroinflamación, provoca una desregulación de la homeostasis de la glucosa y aumenta el estrés oxidativo, exacerbando la degeneración de la retina en los ratones rd10. Así, los resultados de este estudio pueden ser extrapolados a otras enfermedades con características comunes. Además, sería recomendable para pacientes con enfermedades neurodegenerativas de retina moderar su consumo de dietas ricas en grasa. En resumen, los distintos estudios ponen de manifiesto la necesidad de desarrollar nuevos fármacos para el tratamiento de enfermedades neurodegenerativas de la retina, así como, la necesidad de estudiar los factores ambientales que podrían afectar al ritmo del proceso degenerativo asociado a estas enfermedades.
RUA. Repositorio Institucional de la Universidad de Alicante
Publicación Otros (Other)

Retinal Vascular Degeneration in the Transgenic P23H Rat Model of Retinitis Pigmentosa

  • Fernández-Sánchez, Laura
  • Esquiva, Gema
  • Pinilla Lozano, Isabel
  • Lax, Pedro
  • Cuenca, Nicolás
  • Cuenca, Nicolás|||/items/9aff7e32-82c7-4c3b-9e61-c644ea7f9ec8
  • Esquiva, Gema|||/items/c732fed4-c592-4084-9dc2-20bebb68f96c
  • Fernández-Sánchez, Laura|||/items/1676ebd7-acc8-4ea8-bff6-d2b805dae60b
  • Lax, Pedro|||/items/4cc55375-3e6f-40f5-b3dc-8b55eb7dd8a7
Retinitis pigmentosa (RP) is a group of inherited retinal degenerative diseases involving a progressive degeneration of photoreceptor cells. Following the loss of photoreceptors, retinal vascularization tends to decrease, which seems to play a role in the degenerative process of retinal cells. This study reports changes in retinal vascular network architecture in the P23H rat model of RP at different stages of retinal degeneration. Homozygous P23H line-3 rats of ages ranging from 18 days to 16 months were used in this study. Age-matched Sprague-Dawley (SD) rats were used as control animals. Vertical sections and wholemount retinas were immunolabeled for type IV collagen or stained using NADPH diaphorase histochemistry, and retinal vascular networks were drawn using a camera lucida. The superficial and deep capillary plexus (DCP) were fully developed at P18 in P23H rat retinas and showed no differences from the control animals. In 4-month-old P23H rat retinas, the superficial and intermediate capillary plexus were similar to those observed in age-matched SD rats, but a reduction in the DCP could be observed in these animals, with a significant decrease in both capillary density and capillary loops. At 16 months, the DCP was completely lost, and only vessels exhibiting an abnormal, tortuous dead-end could be observed. The middle capillary plexus had virtually disappeared at this age. Only perpendicular vessels connecting the superficial and DCP were found. The superficial plexus showed no changes in the vascular surface with age. In RP, photoreceptor loss is accompanied by degenerative changes in the retinal vascular network. The disruption of the capillary plexus, with loss of capillary density and capillary loops, can hamper the normal supply of oxygen and nutrients to retinal cells, thus accelerating retinal degeneration. Therefore, changes in retinal vascularization must be taken into account in the design of therapies targeting retinal degenerative diseases.
RUA. Repositorio Institucional de la Universidad de Alicante
Publicación Otros (Other)

Cannabinoid-mediated retinal rescue correlates with improved circadian parameters in retinal dystrophic rats

  • Lax, Pedro
  • Kutsyr, Oksana
  • Esquiva, Gema
  • Altavilla, Cesare
  • Maneu, Victoria
  • Cuenca, Nicolás
  • Altavilla, Cesare|||/items/17ebf887-44db-4aba-8925-aa6a30321036
  • Cuenca, Nicolás|||/items/9aff7e32-82c7-4c3b-9e61-c644ea7f9ec8
  • Esquiva, Gema|||/items/c732fed4-c592-4084-9dc2-20bebb68f96c
  • Lax, Pedro|||/items/4cc55375-3e6f-40f5-b3dc-8b55eb7dd8a7
  • Maneu, Victoria|||/items/4619afed-7005-432f-96ee-e192fd5bfbe4
Ocular pathologies and blindness have been linked to circadian disorders. In previous studies, our group has demonstrated that retinitis pigmentosa is associated with degenerative changes in the melanopsin system and weaker circadian patterns. We have also shown that cannabinoids preserve retinal structure and function in dystrophic P23H rats. This study is consequently aimed at examining whether the morphologic and functional rescue of retinal degeneration by cannabinoids is associated with amelioration of circadian parameters. The synthetic cannabinoid HU210 (100 μg/kg, i.p.) or vehicle were administered to transgenic P23H rats three times per week, from postnatal day 24–90. Sprague-Dawley rats were used as a healthy control group. Locomotor activity and scotopic electroretinograms were recorded, and the retinal structure was analyzed at the end of the experiment. The ERG a- and b-wave amplitudes and photoreceptor cell number were more deteriorated in vehicle-administered P23H rats as compared to P23H rats treated with HU210. In cannabinoid-administered P23H rats, the locomotor activity circadian rhythms showed less disturbance than that observed in vehicle-administered P23H rats, the latter showing lower values for mesor, amplitude, acrophase, percentage of variance and non-parametric variables. A positive linear correlation was found between retinal values and circadian parameters of locomotor activity from P23H rats. This study thus provides evidence of a positive correlation between cannabinoid-mediated rescue of retinal structure and function and improvement of circadian rhythmicity.
RUA. Repositorio Institucional de la Universidad de Alicante
Publicación Otros (Other)

Systemic inflammation induced by lipopolysaccharide aggravates inherited retinal dystrophy

  • Noailles, Agustina
  • Maneu, Victoria
  • Campello Blasco, Laura
  • Lax, Pedro
  • Cuenca, Nicolás
  • Cuenca, Nicolás|||/items/9aff7e32-82c7-4c3b-9e61-c644ea7f9ec8
  • Lax, Pedro|||/items/4cc55375-3e6f-40f5-b3dc-8b55eb7dd8a7
  • Maneu, Victoria|||/items/4619afed-7005-432f-96ee-e192fd5bfbe4
Retinal neurodegenerative diseases involve a scenario of inflammation and cell death that leads to morphological alterations and visual impairment. Non-ocular inflammatory processes could affect neurodegenerative retinal disorders and their progression, at least in part by activating microglial cells and releasing pro-inflammatory cytokines. Our purpose was to study the consequences of a systemic inflammatory process in the progression of retinal degeneration in P23H rats, a retinitis pigmentosa (RP) model. In order to induce a mild chronic systemic inflammation, we administered low doses of lipopolysaccharide (LPS) from age P20 to P60 to dystrophic P23H rats and healthy SD rats. Visual responsiveness was assessed by electroretinography (ERG). The morphological state of the retinas was analyzed by fluorescent immunohistochemistry (IHC), evaluating the number, morphology, and connectivity of different neuronal populations by means of cell type-specific markers. Microglia density, distribution, and degree of activation were evaluated by IHC and flow cytometry. The expression levels of inflammation- and apoptosis-related genes were analyzed by qRT-PCR arrays. Low-dose LPS administration did not induce significant functional or morphological changes in the retina of SD rats, although at the molecular level, we detected expression changes in genes related to apoptosis. Otherwise, systemic injection of LPS into P23H rats induced a further deterioration in the ERG response, with greater loss of photoreceptors and worsening of synaptic connectivity, accompanied by increasing numbers of microglial cells, which also showed a more intense activation state. Several inflammation- and apoptosis-related genes were upregulated. Our results indicate that chronic exacerbation of the inflammatory response in response to LPS accelerates neurodegeneration in dystrophic P23H rats, suggesting that in patients with ocular neurodegenerative diseases, peripheral damage, as a systemic infection or chronic inflammatory process, could accelerate disease progression, and should be taken into account in order to select an appropriate therapy to revert, block or slow-down the degenerative process.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Controlled delivery of tauroursodeoxycholic acid from biodegradable microspheres slows retinal degeneration and vision loss in P23H rats

  • Fernandez-Sanchez, L.
  • Bravo-Osuna, I.
  • Lax, P.
  • Arranz-Romera, A.
  • Maneu, V.
  • Esteban-Perez, S.
  • Pinilla, I.
  • Puebla-Gonzalez, M.D.
  • Herrero-Vanrell, R.
  • Cuenca, N.
Successful drug therapies for treating ocular diseases require effective concentrations of neuroprotective compounds maintained over time at the site of action. The purpose of this work was to assess the efficacy of intravitreal controlled delivery of tauroursodeoxycholic acid (TUDCA) encapsulated in poly(D, L-lactic-co-glycolic acid) (PLGA) microspheres for the treatment of the retina in a rat model of retinitis pigmentosa. PLGA microspheres (MSs) containing TUDCA were produced by the O/W emulsion-solvent evaporation technique. Particle size and morphology were assessed by light scattering and scanning electronic microscopy, respectively. Homozygous P23H line 3 rats received a treatment of intravitreal injections of TUDCA-PLGA MSs. Retinal function was assessed by electroretinography at P30, P60, P90 and P120. The density, structure and synaptic contacts of retinal neurons were analyzed using immunofluorescence and confocal microscopy at P90 and P120. TUDCA-loaded PLGA MSs were spherical, with a smooth surface. The production yield was 78%, the MSs mean particle size was 23 mu m and the drug loading resulted 12.5 +/- 0.8 mu g TUDCA/mg MSs. MSs were able to deliver the loaded active compound in a gradual and progressive manner over the 28-day in vitro release study. Scotopic electroretinografic responses showed increased ERG a- and b-wave amplitudes in TUDCA-PLGA-MSstreated eyes as compared to those injected with unloaded PLGA particles.TUDCA-PLGAMSs- treated eyes showed more photoreceptor rows than controls. The synaptic contacts of photoreceptors with bipolar and horizontal cells were also preserved in P23H rats treated with TUDCA-PLGA MSs. This work indicates that the slow and continuous delivery of TUDCA from PLGA-MSs has potential neuroprotective effects that could constitute a suitable therapy to prevent neurodegeneration and visual loss in retinitis pigmentosa.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Retinal Vascular Degeneration in the Transgenic P23H Rat Model of Retinitis Pigmentosa

  • Fernández-Sánchez, Laura
  • Esquiva, Gema
  • Pinilla, Isabel
  • Lax, Pedro
  • Cuenca, Nicolás
Retinitis pigmentosa (RP) is a group of inherited retinal degenerative diseases involving a progressive degeneration of photoreceptor cells. Following the loss of photoreceptors, retinal vascularization tends to decrease, which seems to play a role in the degenerative process of retinal cells. This study reports changes in retinal vascular network architecture in the P23H rat model of RP at different stages of retinal degeneration. Homozygous P23H line-3 rats of ages ranging from 18 days to 16 months were used in this study. Age-matched Sprague-Dawley (SD) rats were used as control animals. Vertical sections and wholemount retinas were immunolabeled for type IV collagen or stained using NADPH diaphorase histochemistry, and retinal vascular networks were drawn using a camera lucida. The superficial and deep capillary plexus (DCP) were fully developed at P18 in P23H rat retinas and showed no differences from the control animals. In 4-month-old P23H rat retinas, the superficial and intermediate capillary plexus were similar to those observed in age-matched SD rats, but a reduction in the DCP could be observed in these animals, with a significant decrease in both capillary density and capillary loops. At 16 months, the DCP was completely lost, and only vessels exhibiting an abnormal, tortuous dead-end could be observed. The middle capillary plexus had virtually disappeared at this age. Only perpendicular vessels connecting the superficial and DCP were found. The superficial plexus showed no changes in the vascular surface with age. In RP, photoreceptor loss is accompanied by degenerative changes in the retinal vascular network. The disruption of the capillary plexus, with loss of capillary density and capillary loops, can hamper the normal supply of oxygen and nutrients to retinal cells, thus accelerating retinal degeneration. Therefore, changes in retinal vascularization must be taken into account in the design of therapies targeting retinal degenerative diseases.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Epigallocatechin gallate slows retinal degeneration, reduces oxidative damage, and modifies circadian rhythms in P23H Rats

  • Perdices, Lorena
  • Fuentes-Broto, Lorena
  • Segura, Francisco
  • Cuenca, Nicolás
  • Orduna-Hospital, Elvira
  • Pinilla, Isabel
Retinitis pigmentosa (RP) includes a group of genetic disorders that involve the loss of visual function due to mutations mainly in photoreceptors but also in other retinal cells. Apoptosis, retinal disorganization, and inflammation are common in the progression of the disease. Epigallocatechin gallate (EGCG) has been proved as beneficial in different eye diseases. Pigmented heterozygous P23H rat was used as an animal model of RP. Visual function was assessed by optomotor and electroretinogram (ERG) and circadian rhythms were evaluated by telemetry. Hepatic oxidative damage and antioxidant defenses were assessed using biochemical tests. The visual function of the EGCG P23H group was preserved, with a deterioration in the activity period and lower values in the interdaily stability parameter. Control rats treated with EGCG were less active than the sham group. EGCG increased antioxidant levels in P23H rats but reduced total hepatic antioxidant capacity by almost 42% in control rats compared to the sham group. We conclude that treatment with EGCG improves visual function and antioxidant status in P23H rats but diminishes antioxidant defenses in wild-type control animals, and slightly worsens activity circadian rhythms. Further studies are necessary to clarify the beneficial effects in disease conditions and in healthy organisms.